Therapeutic Hypothermia After Cardiac Arrest

John McPherson

TCT 2024 Insights: Insights from the DanGer Shock and ECLS-Shock Tri…

TCT 2024 Insights

G. Tarantini

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

TACT2 – Does Chelation Reduce Events in Diabetic Post-MI Patients?

Canadian Collaborative Research Network

N. Singh

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

ECMO for Refractory Cardiac Arrest: Mobile MN Community Efforts and …

University of Minnesota

D. Yannopoulos

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

UChicago Medicine

S. Nathan

ACC 2022: High Sensitivity Troponin in the Evaluation of Acute Chest…

ACC 2022 Conference Coverage

A. Jaffe

ECPR Criteria and Prognostication

University of Minnesota

J. Bartos

Cardiogenic Shock: All Mechanical Circulatory Support Devices

Complex Coronary Cases

G. Serrao

Infarct Reduction in Anterior STEMI and Cardiogenic Shock: Supersatu…

ARCH Advanced Revascularization Symposium

S. Lynch